NCCN has a large active presence in Latin America and translations of NCCN Guidelines® in Portuguese and Spanish are available on the International Adaptations & Translations page.
Since 2011, NCCN has worked with the Latin American Cooperative Oncology Group (LACOG) to develop Latin America Editions of the NCCN Guidelines for Breast, Colon, Non-Small Cell Lung, Prostate Cancer, Multiple Myeloma, and Rectal Cancers. LACOG is a non-profit organization founded in 2008 by a group of Latin American medical oncologists interested in the development of academic clinical research. LACOG is the first multinational cooperative group in Latin America exclusively dedicated to clinical and translational research in cancer.
In 2015, NCCN participated in two of the most renowned oncology congresses in Brazil. In September, Joan S. McClure, MS, Senior Vice President of Clinical Information and Publications, NCCN, traveled to Brasilia, Brazil to participate in the 20th Brazilian Oncology Congress, and Robert W. Carlson, MD, Chief Executive Officer, NCCN, traveled to Iguazu Falls, Brazil to present at the Brazilian Oncology Society Congress in October. Each congress brought together thousands of national and international oncology professionals covering various areas of advancement in the treatment and management of cancer in Brazil.
Cancer is the second leading cause of death in the Caribbean, and the rate of breast cancer deaths is currently twice that of the United States. The archipelago that extends from the Bahamas in the north to Trinidad and Tobago in the south ranks among the highest regions in the world for cancer prevalence.
To support practitioners in the region, NCCN embarked on a new collaboration with the Caribbean Association for Oncology & Hematology (CAOH). These tailored resources were developed to better reflect the diverse needs and resources throughout the Caribbean.
“This international partnership between CAOH and NCCN will enable doctors throughout the Caribbean to provide the best possible care for people with cancer,” said Marisa Nimrod, MD, Chairman and Chief Executive Officer, CAOH. “We look forward to creating a blueprint for improving treatment outcomes, and tailoring the available resources to meet the demands of structured, evidence-based cancer prevention and control. These guidelines will also help inform governmental policies in the future.”